ICU Medical Inc (ICUI) Financials
Key financial figures for ICU Medical Inc (Q3 2026).
ICU Medical's Q3 2026 revenue rose to $560.4M from $537.0M a year earlier, with GAAP net income of $26.8M against a $3.4M loss, and management reaffirmed FY2026 guidance while expecting the high end of the range. GAAP revenue was $560.4M versus $537.0M in Q3 2025; GAAP gross margin was 42% versus 37%, and GAAP diluted EPS was $1.07 versus $(0.14). Adjusted diluted EPS was $2.44 versus $2.03 a year earlier, and Adjusted EBITDA was $113.9M versus $105.9M. The release does not print a consensus estimate, so no beat or miss is stated. By product line: Consumables $298.4M (about +5% GAAP year over year), Infusion Systems $192.5M (about +11%), and Vital Care $69.5M (about -11%) after the May 2025 IV Solutions sale. On the outlook: Full-year 2026 guidance reaffirmed, with results expected toward the higher end of the range: GAAP net income $73M to $83M, GAAP diluted EPS $2.89 to $3.29, Adjusted EBITDA $415M to $435M, adjusted diluted EPS $8.60 to $9.00. Figures are for Q3 2026, as ICU Medical reported them.
- Revenue
- $560M
- Net Income
- $27M
- EPS
- $1.07
- Total Assets
- $3.9B
- Operating Cash Flow
- $100M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $560M | $27M | $1.07 | 9.34% | $83M |
| Q2 FY2026 | $552M | $19M | $0.76 | 7.09% | $62M |
| Q1 FY2026 | $530M | $30M | $1.20 | 2.56% | $28M |
| Q4 FY2025 | $540M | -$16M | -$0.64 | 4.67% | $36M |
| Q3 FY2025 | $537M | -$3M | -$0.14 | 2.55% | $28M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $2.2B | $732K | $0.03 | 1.92% | $92M |
| FY2024 | $2.4B | -$118M | -$4.83 | 1.8% | $125M |
| FY2023 | $2.3B | -$30M | -$1.23 | 1.01% | $73M |
Frequently asked questions
What was ICU Medical's revenue last quarter?
ICU Medical reported revenue of $560.4 million for Q3 FY2026, up 4.4% from the same period a year earlier.
Is ICU Medical profitable?
Yes. ICU Medical reported net income of $26.8 million for Q3 FY2026, a net margin of 4.79% on revenue.
How has ICU Medical's margin trended?
Operating margin was 9.34% in Q3 FY2026, compared with 2.55% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did ICU Medical generate?
ICU Medical generated free cash flow of $83.4 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for ICU Medical Inc on SentiSense, with up to forty quarters and twenty fiscal years of history.